74
Participants
Start Date
January 31, 2003
Primary Completion Date
December 31, 2006
Study Completion Date
June 30, 2010
Fibrin Sealant (Tisseel) used in the Experimental Arm.
"For patients in the Experimental (Treatment) Arm, 4 ml of Tisseel fibrin sealant were instilled into the wound using the Duploject™ spray delivery system prior to wound closure. Tisseel™ fibrin sealant was provided by Baxter Healthcare Ltd., Newbury, Berkshire, UK.~For patients in the Active Comparator (Control) Arm, no fibrin sealant was used during wound closure (with the surgical procedure being identical in all other respects)."
Baxter Healthcare Corporation
INDUSTRY
Oxford University Hospitals NHS Trust
OTHER